 | | | | HAIFA, Israel (Reuters) - Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug Administration has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event. | | | | | | LONDON (Reuters) - Scotland introduced minimum unit pricing on alcohol on Tuesday as it tries to improve public health by raising the cost of cheap, strong drinks favored by young people and binge-drinkers. | | | | | | (Reuters) - U.S. appeals court judges appear divided over whether to allow a research center affiliated with MIT and Harvard to keep patents potentially worth billions of dollars on a groundbreaking gene editing technology known as CRISPR. | | | | | | (Reuters Health) - People with rheumatoid arthritis and obesity may be more likely to become disabled than their counterparts who maintain a healthier weight, a U.S. study suggests. | | | | | | (Reuters Health) - Adults who follow a healthy lifestyle in middle age may extend their lifespan by more than a decade and have a lower risk of dying from cancer or heart disease, a U.S. study suggests. | | | | | | (Reuters Health) - People with moderate to severe anxiety in middle age may be more likely to develop dementia as they get older, a recent study suggests. | | | | | | (Reuters) - Fourteen more people fell ill from an E. coli outbreak linked to romaine lettuce, U.S. health officials said on Friday, bringing the number of people affected to 98 across 22 U.S. states. | | | | | | HONG KONG (Reuters) - When Hong Kong unveiled plans last year to encourage biotech companies to list in the city by loosening listing rules, the financial industry and investors cheered. | | | | | | (Reuters Health) - African-Americans admitted to the intensive care unit (ICU) for heart failure are less likely than white patients to receive care by a cardiologist. | | | | | | NEW YORK (Reuters) - Allergan Plc on Friday announced positive results from a second Phase III trial for the 50 milligram dose of its drug for acute migraine, reproducing results from the previous trial. | | | | | |
